Editor’s Highlight: Development of anIn vitroAssay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment
Open Access
- 7 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 154 (1) , 162-173
Abstract
A toxicity pathway approach was taken to develop an in vitro assay using human uterine epithelial adenocarcinoma (Ishikawa) cells as a replacement for measuring an in vivo uterotrophic response to estrogens. The Ishikawa cell was determined to be fit for the purpose of recapitulating in vivo uterine response by verifying fidelity of the biological pathway components and the dose-response predictions to women of child-bearing age. Expression of the suite of estrogen receptors that control uterine proliferation (ERα66, ERα46, ERα36, ERβ, G-protein coupled estrogen receptor (GPER)) were confirmed across passages and treatment conditions. Phenotypic responses to ethinyl estradiol (EE) from transcriptional activation of ER-mediated genes, to ALP enzyme induction and cellular proliferation occurred at concentrations consistent with estrogenic activity in adult women (low picomolar). To confirm utility of this model to predict concentration-response for uterine proliferation with xenobiotics, we tested the concentration-response for compounds with known uterine estrogenic activity in humans and compared the results to assays from the ToxCast and Tox21 suite of estrogen assays. The Ishikawa proliferation assay was consistent with in vivo responses and was a more sensitive measure of uterine response. Because this assay was constructed by first mapping the key molecular events for cellular response, and then ensuring that the assay incorporated these events, the resulting cellular assay should be a reliable tool for identifying estrogenic compounds and may provide improved quantitation of chemical concentration response for in vitro-based safety assessments.Keywords
This publication has 54 references indexed in Scilit:
- Differential Ligand Binding Affinities of Human Estrogen Receptor-α IsoformsPLOS ONE, 2013
- Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory FactorCell Reports, 2013
- Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting ChemicalsEnvironmental Health Perspectives, 2013
- Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast DataEnvironmental Health Perspectives, 2010
- ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK PathwayPLOS ONE, 2010
- The EDKB: an established knowledge base for endocrine disrupting chemicalsBMC Bioinformatics, 2010
- Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcriptionMolecular and Cellular Endocrinology, 2010
- In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast ProjectEnvironmental Health Perspectives, 2010
- Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancerBreast Cancer Research, 2007
- A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signalingProceedings of the National Academy of Sciences, 2006